process
viabl
cell
clearanc
via
phagocytosi
macrophag
term
us
program
cell
remov
prcr
consist
multipl
step
includ
recognit
cellular
engulf
intracellular
digest
target
conserv
mani
metazoan
phagocytosi
cell
undergo
pcd
yet
burst
presum
prevent
die
cell
content
caus
phagocytosi
often
tie
program
cell
death
pcd
essenti
clearanc
apoptot
cell
call
prcr
occur
mani
circumst
independ
shown
initi
pcd
prcr
occur
age
neutrophil
pcd
block
enforc
express
prcr
block
result
physiolog
remov
prcr
live
cell
play
integr
role
mani
physiolog
pathophysiolog
process
includ
inflamm
hematopoiesi
tissu
turnov
cancer
process
viabl
target
cell
clear
macrophag
prcr
without
pcd
induc
efficaci
prcr
determin
balanc
recognit
prophagocyt
eat
signal
macrophag
inhibit
macrophag
via
activ
antiphagocyt
eat
pathway
target
cell
cancer
cell
upregul
eat
signal
inhibit
prcr
macrophag
signal
via
macrophag
signal
regulatori
protein
blockad
cancer
cell
lead
recognit
phagocytosi
via
cell
surfac
form
effector
calreticulin
crt
bind
cancer
cell
macrophag
receptor
lead
andor
activ
tyrosin
phosphatas
inhibit
phagocytosi
macrophagebound
target
least
part
dephosphoryl
actinmyosinpaxillin
compon
requir
engulf
er
lumen
crt
function
chaperon
assist
fold
assembl
list
cell
surfac
secret
protein
includ
major
histocompat
complex
mhc
class
well
er
resid
protein
includ
chaperon
crt
also
found
regul
adhes
integrin
integrin
demonstr
regul
crt
present
cell
interact
crt
cell
surfac
implic
signal
lowdens
lipoprotein
ldl
receptorrel
protein
induc
focal
adhes
disassembl
cell
surfac
crt
receptor
form
bridg
complex
macrophag
apoptot
cell
activ
cellular
machineri
respons
initi
phagocytosi
apoptot
normal
tissu
cell
becom
suscept
prcr
signal
block
due
lack
eat
signal
necessari
macrophag
thu
macrophag
integr
pro
antiphagocyt
signal
cellular
target
either
phagocytos
allow
remain
system
regul
oppos
signal
stringent
defin
specif
select
prcr
clearanc
unwant
cell
supplementari
fig
enabl
induct
prcr
promis
cancer
treatment
approach
high
efficaci
minor
nonspecif
toxic
despit
import
littl
known
regard
macrophag
detect
recogn
target
cell
prcr
whether
gener
mechan
share
among
prcr
differ
type
unwant
cell
includ
damag
dysfunct
age
malign
cell
similar
identifi
prcr
apoptot
cell
live
cell
emerg
evid
distinct
mechan
may
regul
two
recent
studi
identifi
crt
guid
target
live
cancer
cell
show
crt
move
endoplasm
reticulum
macrophag
cell
surfac
andor
secret
follow
macrophag
activ
via
toll
like
process
involv
btk
phosphoryl
endoplasm
reticulum
crt
cleavag
separ
er
retent
kdel
rest
protein
secret
bridg
macrophag
prophagocyt
receptor
appropri
target
dissect
mechan
crtmediat
recognit
live
cell
destin
prcr
studi
demonstr
intrins
chang
target
cell
result
suscept
bind
macrophagesecret
crt
label
target
cell
subsequ
remov
prcr
reveal
surpris
cell
undergo
prcr
reveal
crtbind
moieti
cell
surfac
moieti
famili
asialoglycan
express
pathway
regul
crt
bind
human
cancer
correl
prognost
outcom
patient
cancer
gener
crtbind
site
cancer
cell
therefor
enhanc
prcr
could
import
develop
highli
effici
cancer
treatment
strategi
show
gener
mechan
interact
macrophag
target
cell
prcr
mani
physiolog
pathophysiolog
condit
least
one
case
target
cell
induc
cellsurfac
asialoglycoprotein
function
neuraminidas
share
mechan
prcr
nonmalign
cell
open
path
test
therapi
diseas
cell
protect
includ
wide
rang
human
cancer
cell
atherosclerot
cell
fibrot
diseas
steril
infectioninduc
periton
immatur
neutrophil
leav
bone
marrow
infiltr
inflamm
site
matur
neutrophil
program
initi
agedepend
cell
apoptot
process
phagocytos
periton
macrophag
explos
releas
cellular
content
would
caus
inflamm
burst
insid
macrophag
util
mous
model
neutrophil
resist
cell
death
enforc
express
promot
agreement
previou
find
use
anim
model
found
thioglycol
induc
periton
neutrophil
resist
apoptosi
remov
peritoneum
tempor
dynam
wt
neutrophil
undergo
cell
death
fig
b
supplementari
fig
data
indic
age
neutrophil
program
remov
prcr
therefor
recognit
target
cell
macrophag
independ
cell
death
reason
cell
death
prcr
program
activ
wildtyp
wt
neutrophil
promot
remov
peritoneum
prcr
activ
neutrophil
fig
reveal
potenti
pathway
util
neutrophil
activ
prcr
perform
geneexpress
profil
use
rnaseq
analysi
compar
immatur
bonemarrow
neutrophil
matur
peritoneuminfiltr
neutrophil
wt
mice
fig
supplementari
fig
time
neutrophil
start
remov
peritoneum
identifi
overlap
gene
upregul
wt
neutrophil
potenti
involv
prcr
fig
supplementari
fig
gene
ontolog
enrich
pathway
analys
reveal
enrich
pathway
mapk
signal
cascad
respons
stress
immun
system
process
fig
wonder
whether
modif
cell
surfac
chang
promot
cell
commun
lead
prcr
evalu
cell
surfac
chang
neutrophil
macrophag
eat
eat
signal
crt
respect
regul
prcr
thioglycol
inject
mice
fig
b
found
prcr
neutrophil
thioglycol
inject
correl
cell
surfac
express
crt
fig
supplementari
fig
interestingli
cell
surfac
level
crt
increas
neutrophil
time
correl
loss
neutrophil
peritoneum
data
indic
cell
surfac
dynam
chang
time
prcr
occur
promot
crt
accumul
neutrophil
test
isol
macrophag
neutrophil
thioglycol
inject
period
time
determin
capac
cell
bind
recombin
crt
macrophag
neutrophil
time
modifi
cell
surfac
becom
less
recept
bind
exogen
crt
fig
macrophag
becam
less
recept
bind
crt
neutrophil
becam
recept
bind
crt
data
indic
cell
surfac
crt
regul
prcr
neutrophil
model
test
conduct
phagocytosi
assay
block
crt
recognit
crt
block
antibodi
found
phagocytosi
viabl
neutrophil
macrophag
condit
significantli
decreas
fig
data
emphas
prcr
dynam
process
prcr
viabl
cell
depend
larg
appear
cell
surfac
target
crt
bind
investig
molecular
mechan
crtmediat
prcr
neutrophil
examin
origin
cell
surfac
crt
deathless
neutrophil
interestingli
neutrophil
express
extrem
low
level
crt
macrophag
express
high
level
crt
rna
protein
level
suggest
surfac
crt
molecul
neutrophil
may
origin
macrophag
fig
supplementari
fig
test
isol
periton
macrophag
thioglycol
inject
found
readili
secret
crt
fig
stimul
macrophag
lp
promot
crt
secret
suggest
macrophag
util
mechan
crt
secret
promot
prcr
supplementari
fig
evalu
sourc
crt
cultur
neutrophil
macrophag
alon
togeth
measur
cell
surfac
crt
level
neutrophil
alter
cell
surfac
level
crt
respect
time
cultur
alon
supplementari
fig
howev
cocultur
neutrophil
macrophag
separ
pore
membran
boyden
chamber
show
rapid
signific
increas
cell
surfac
crt
neutrophil
fig
supplementari
fig
determin
possibl
macrophag
could
produc
crt
transfer
neutrophil
metabol
label
activ
macrophag
aha
lazidohomoalanin
methionin
analog
label
newli
synthes
protein
cocultur
cell
neutrophil
separ
macrophag
pore
membran
boyden
chamber
fig
click
reaction
abl
incorpor
biotin
aha
posit
protein
neutrophil
immunoprecipit
crt
follow
western
blot
analysi
immunoprecipit
probe
biotin
streptavidinhrp
found
biotin
posit
crt
neutrophil
indic
macrophag
secret
crt
decor
surfac
deathless
neutrophil
absenc
contact
macrophag
neutrophil
fig
supplementari
fig
consid
possibl
macrophag
modifi
target
cell
cytokin
secret
examin
cytokin
profil
macrophag
differ
circumst
block
crt
macrophag
didnot
affect
cytokin
profil
except
upregul
groa
two
inflammatori
cytokin
supplementari
fig
addit
signific
differ
observ
regard
cytokin
secret
macrophag
cocultur
boyden
chamber
neutrophil
wt
mice
supplementari
fig
data
indic
direct
modif
target
cell
via
cytokin
macrophag
major
mechan
activ
prcr
howev
dynam
interplay
promot
macrophag
secret
crt
neutrophil
accumul
next
sought
identifi
crtbind
site
neutrophil
target
prcr
better
understand
basic
mechan
cell
interact
prcr
crt
function
lectinchaperon
er
bind
newli
synthes
glycoprotein
assist
fold
abnorm
cellsurfac
glycosyl
report
apoptot
cell
cancer
therefor
hypothes
macrophagesecret
crt
maintain
lectinlik
characterist
bind
target
cell
via
cell
surfac
glycoprotein
perhap
glycan
crt
bind
thu
perform
screen
experi
probe
carbohydr
contain
larg
number
tumor
glycan
molecul
recombin
crt
found
crt
select
bound
tumorassoci
asialoglycan
display
triantennari
multival
type
ii
chain
epitop
trimii
fig
phytohaemagglutininl
phal
lectin
previous
demonstr
specif
bind
trimii
domin
supplementari
fig
mimic
crtbind
kinet
neutrophil
macrophag
demonstr
time
bind
site
crt
detect
neutrophil
less
detect
macrophag
fig
found
newli
produc
neutrophil
display
crtbind
site
compar
matur
neutrophil
treatment
neuraminidas
glycosid
hydrolas
enzym
remov
sialic
acid
termin
posit
glycan
expos
cryptic
trimii
dramat
increas
crt
bind
group
fig
data
confirm
crt
bind
viabl
cell
promot
prcr
via
asialoglycoprotein
examin
crt
bind
cell
surfac
glycan
molecul
use
wt
mutant
cho
cell
line
specif
express
trimii
stronger
bind
recombin
crt
observ
cho
line
defect
cmpsialic
acid
transport
udpglcnac
epimeras
express
trimii
compar
parent
line
line
defect
udpgal
translocas
express
trimii
cap
sialic
acid
miss
mannos
outermost
layer
supplementari
fig
next
sought
determin
whether
mechan
function
recognit
phagocytosi
target
cell
prcr
biolog
process
previous
demonstr
prcr
critic
macrophagemedi
cancer
immunosurveil
examin
express
role
crtbind
site
cancer
cell
found
activ
macrophag
cancer
cell
abl
releas
signific
amount
crt
medium
cultur
supplementari
fig
addit
examin
presenc
crtbind
site
human
aml
cell
line
human
colon
cancer
cell
line
found
endogen
crt
either
express
low
level
limit
perinuclear
region
signific
portion
phal
stain
observ
cell
surfac
fig
f
recombin
crt
bound
cell
coloc
phal
cell
surfac
indic
crt
depend
presenc
cyptic
trimii
domain
bind
supplementari
fig
shown
live
age
cancer
cell
directli
phagocytos
macrophag
without
cell
death
supplementari
fig
b
clearanc
live
cancer
cell
prcr
due
induct
cell
death
prcr
cancer
cell
engulf
digest
insid
macrophag
supplementari
fig
observ
crt
bridg
target
cell
macrophag
prcr
via
asialoglycan
cell
surfac
want
next
determin
whether
manipul
asialoglycan
epitop
normal
neoplast
cell
promot
prcr
inde
found
crt
bind
cancer
cell
markedli
enhanc
neuraminidas
treatment
specif
asialoglycan
fig
treatment
significantli
promot
phagocytosi
wide
rang
human
cancer
cell
either
human
mous
macrophag
fig
f
supplementari
fig
determin
whether
neuraminidas
respons
promot
prcr
perform
screen
experi
suppress
express
four
differ
neuraminidas
gene
found
play
major
role
regul
cell
surfac
asialoglycan
epitop
crt
bind
cell
fig
supplementari
fig
consist
suppress
express
significantli
decreas
phagocytosi
cell
fig
taken
togeth
data
demonstr
regul
crtbind
asialoglycan
target
cell
critic
suscept
prcr
produc
cell
intrins
neuraminidas
sinc
exposur
crtbind
site
neuraminidas
treatment
enhanc
phagocytosi
cancer
cell
examin
effect
induc
prcr
xenotranspl
cancer
cell
mice
reduct
tumor
incid
vivo
importantli
treatment
cancer
cell
neuraminidas
show
effect
intrins
program
regul
cell
viabil
prolifer
supplementari
fig
human
leukemia
cell
line
colon
cancer
cell
line
treat
neuraminidas
put
longterm
incub
macrophag
signific
reduct
cancer
cell
number
observ
compar
control
group
supplementari
fig
subcutan
inject
cell
treat
activ
heatinactiv
neuraminidas
nsg
mice
dramat
inhibit
tumor
engraft
growth
observ
cell
treat
activ
neuraminidas
suggest
exposur
crtbind
site
like
promot
prcr
vivo
fig
b
supplementari
fig
base
find
reason
regul
asialoglycan
determin
suscept
prcr
therefor
growth
tumor
cell
express
gene
regul
presenc
asialoglycan
could
correl
diseas
outcom
patient
surviv
assess
correl
express
crtbind
site
clinic
outcom
use
precog
analyz
publish
gene
dataset
contain
correspond
patient
surviv
data
includ
analysi
gene
encod
sialytransferas
neuraminidas
respect
attach
remov
sialic
acid
glycoprotein
thu
mask
unmask
trimii
higher
express
gene
promot
remov
sialic
acid
correl
improv
higher
express
gene
enhanc
sialic
acid
express
correl
wors
fig
found
previous
hematopoiet
stem
cell
hsc
migrat
bone
marrow
circul
increas
express
eat
signal
block
suggest
stem
cell
also
develop
mechan
prcr
selfprotect
therefor
expand
find
hematopoiesi
found
evid
role
crtbind
site
prcr
hsc
current
studi
use
gene
express
platform
contain
gene
express
dataset
differ
cell
type
mous
human
analyz
express
sialytransferas
neuraminidas
hsc
differenti
progeni
hsc
show
significantli
higher
express
sialytransferas
lower
express
neuraminidas
consist
longer
surviv
differenti
progeni
supplementari
fig
next
examin
crt
surfac
level
avail
bind
site
acut
myelogen
leukemia
patholog
model
hematopoiesi
fraction
patient
sampl
residu
normal
hsc
multipot
progenitor
mpp
leukemia
stem
cell
lsc
blast
cell
importantli
stain
surfac
crt
bind
phal
significantli
correl
cell
popul
indic
depend
crt
cell
surfac
bind
asialoglycoprotein
normal
neoplast
cell
fig
tabl
supplementari
fig
consist
much
stronger
phal
stain
found
blast
cell
shortest
halflif
compar
mpp
lsc
hsc
fig
program
cell
remov
common
cellular
process
identifi
mani
physiolog
pathophysiolog
scenario
recent
exploit
treatment
malign
target
serv
eat
signal
block
antibodi
clinic
trial
dramat
efficaci
treatment
preclin
model
human
diseas
includ
patientderiv
xenograft
fibrot
antibodi
function
restor
prcr
minor
toxic
toward
normal
tissu
cell
understand
underli
mechan
prcr
still
infanc
whether
unwant
cell
program
clear
critic
question
understand
tissu
homeostasi
treatment
multipl
patholog
process
tradit
believ
phagocytosi
macrophag
dead
cell
find
start
show
even
without
pcd
phagocytosi
prcr
still
occur
homeostat
regul
cell
also
demonstr
mani
differ
human
primari
tumor
resist
pcd
transplant
orthotop
nsg
mice
suscept
activ
prcr
one
key
player
activ
prcr
crt
eat
signal
discov
crtmediat
detect
mechan
use
macrophag
stringent
specif
respons
abil
distinguish
want
vs
unwant
damag
dysfunct
age
harm
cell
discern
crt
secret
macrophag
bind
asialoglycoprotein
recept
target
cell
nonrecept
cell
asialoglycoprotein
cap
sialic
acid
must
remov
neuraminidas
crt
abl
bind
initi
prcr
cancer
cell
express
significantli
higher
level
crtbind
molecul
sialic
acid
normal
impli
evolv
process
cancer
develop
cancer
cell
respond
intern
signal
eg
also
induc
cell
death
produc
surfac
asialoglycoprotein
perhap
via
secret
neuraminidas
coloc
neuramindas
postgolgi
vesicl
contain
glycoprotein
passiv
acquir
eat
crt
signal
success
cancer
clone
possess
mechan
modifi
signal
express
evad
prcr
recent
publish
also
activ
tumor
ligand
macrophag
receptor
provid
eat
signal
point
import
system
new
knowledg
crt
bind
asialoglycoprotein
often
hidden
sialic
acid
first
step
dissect
mechan
prcr
initi
target
diseas
state
cancer
alon
combin
inhibit
two
fate
neutrophil
pcd
andor
prcr
demonstr
vivo
mice
natur
circumst
show
wildtyp
neutrophil
respons
steril
inflamm
come
periton
caviti
bone
marrow
peak
time
aliv
incub
macrophag
eaten
know
crt
low
h
thioglycol
administr
wildtyp
neutrophil
undergo
endonucleolyt
degrad
chromosom
dna
nucleosom
size
fragment
yet
dead
incub
macrophag
phagocytos
burst
neutrophil
resist
pcd
therefor
undergo
dna
degrad
equal
phagocytos
inflammatori
condit
aliv
detect
neutrophil
either
wt
mice
gone
h
thioglycollatemedi
inflamm
rapid
upregul
crtbind
site
neutrophil
within
h
matur
recruit
peritoneum
induc
steril
periton
implic
increas
neuraminidas
activ
decreas
sialyltransferas
activ
like
mechan
insofar
turnov
cell
surfac
glycoprotein
analog
phenomenon
reinforc
conclus
factor
contribut
prcr
shorter
lifespan
cell
occur
hsc
vs
differenti
hsc
dramat
downregul
respect
sialytransferas
neuraminidas
lead
decreas
crtbind
site
enhanc
antiprcr
protect
longlast
stem
cell
consist
remark
low
futur
studi
need
address
mechan
asialoglycoprotein
produc
primari
cancer
whether
distinct
subgroup
macrophag
involv
decor
engulf
target
cell
final
macrophag
immun
cell
cooper
immunosurveil
asialgoglycanmedi
immun
conclus
found
tissu
turnov
differenti
inflamm
etc
cancer
develop
cell
regul
access
surfac
crtbind
site
turn
control
remov
macrophag
prcr
exposur
asialoglycoprotein
lead
decor
target
cell
crt
secret
macrophag
eventu
trigger
prcr
schemat
summar
supplementari
fig
examin
crtbind
site
cancer
cell
demonstr
prognost
power
potenti
creat
new
treatment
increas
number
site
promot
prcr
wide
rang
human
cancer
cell
diseas
understand
mechan
critic
develop
novel
immunotherapi
fulli
exploit
prcr
elabor
prcr
signal
unoppos
oligopot
hematopoiet
progenitor
least
myelodysplast
syndrom
patient
hsc
singl
cell
chromosom
anomali
monosomi
demonstr
prcr
signal
elicit
singl
differenti
step
transit
md
aml
accompani
upregul
final
larg
number
human
cellular
degen
diseas
exist
mechan
cell
loss
gener
specul
pcd
provid
anoth
also
could
respons
import
implic
studi
first
format
mutant
calreticulin
critic
lesion
half
patient
myeloprolif
neoplasm
mpn
nearli
rest
due
activ
first
clue
puzzl
mutant
calreticulin
one
produc
frameshift
ctermin
domain
lose
bind
neg
charg
amino
acid
replac
posit
charg
amino
acid
second
frameshift
mutant
crt
kdel
domain
mutant
calreticulin
bind
ectodomain
cmpl
signal
via
propos
bind
crt
cmpl
involv
lectin
specif
cmpl
molecul
asialoform
rather
sialyl
protein
therefor
bind
lead
signal
could
wholli
part
due
lectin
domain
secret
crtbind
asialo
cmpl
way
trigger
dimer
signal
perhap
new
ctermin
domain
also
cmpl
bind
may
crosslink
asialoglycan
protein
suffici
could
impli
mpn
form
crt
dimer
via
new
ctermin
domain
shall
also
import
test
whether
glycan
portion
cmpl
crtbind
site
asialoglycan
also
cell
surfac
molecul
cmpl
second
import
implic
studi
bind
phal
asialoglycan
pha
discov
erythrocyt
agglutinin
nowel
notic
also
stimul
nonagglutin
mononuclear
cell
human
peripher
blood
situat
stimul
cell
enter
cell
cycl
nowel
use
display
chromosom
individu
cytogenet
pha
tcell
mitogen
context
paper
like
bind
asialoglycan
residu
mitogen
tcell
surfac
molecul
known
includ
tcr
associ
chain
erythrocyt
specif
pha
bind
could
also
via
asialoglycan
shown
elsewher
cancer
cell
phagocytos
presenc
block
antibodi
cell
display
eat
signal
mice
nhp
human
first
dose
therapeut
antibodi
result
dosedepend
anemia
interpret
due
satur
rbc
plu
eat
signal
crt
made
sinusoid
macrophag
balbc
balbc
fvb
nodcgprkdcscid
nsg
mice
bred
pathogenfre
facil
institut
stem
cell
biolog
regen
medicin
stanford
univers
anim
resourc
center
citi
hope
comprehens
cancer
center
wildtyp
transgen
fvb
mice
use
isol
analysi
periton
macrophag
neutrophil
transgen
mice
human
express
control
human
regulatori
anim
procedur
accord
guidelin
approv
administr
panel
laboratori
anim
care
stanford
univers
citi
hope
comprehens
cancer
center
human
cancer
deriv
cell
line
murin
macrophagemonocyt
cell
line
obtain
atcc
addit
cell
authent
mycoplasma
examin
perform
cell
routin
cultur
dmem
medium
supplement
fetal
bovin
serum
imdm
medium
supplement
fetal
bovin
serum
medium
supplement
fetal
bovin
serum
cho
mutant
line
identifi
parent
clone
defect
cmpsialic
acid
transport
clone
defect
udpglcnac
epimeras
clone
defect
udpgal
translocas
cell
cultur
alphamem
gibco
supplement
fetal
calf
serum
cell
maintain
suspens
monolay
lenti
viral
vector
express
luciferaseegfp
fusion
protein
luciferaserfp
fusion
protein
transfect
cell
gener
lenti
virus
use
transduc
tumor
cell
egfp
lenti
virus
macrophag
cell
rfp
lenti
virus
cell
sort
flow
cytometri
bd
facsaria
ii
cell
sorter
gfp
rfp
episom
mammalian
express
vector
thermo
fisher
use
express
recombin
crtiggfc
protein
gener
mous
bone
marrowderiv
macrophag
bone
marrow
cell
isol
nsg
mice
week
old
cell
treat
ack
lysi
buffer
min
cultur
imdm
medium
supplement
fb
ng
mcsf
day
differenti
macrophag
gener
human
peripher
bloodderiv
macrophag
monocyt
enrich
human
peripher
blood
purchas
stanford
blood
center
cultur
imdm
supplant
human
serum
day
differenti
macrophag
periton
lavag
conduct
indic
time
inject
ml
thioglycol
medium
difco
ip
neutrophil
collect
lavag
indic
time
wash
rpmi
macrophag
allow
adher
plate
rpmi
medium
h
nonadher
cell
collect
fortyeight
hour
inject
periton
cell
collect
use
downstream
applic
thioglycol
elicit
macrophag
cultur
cell
per
well
supplement
serum
plate
macrophag
cocultur
neutrophil
use
pore
transwel
corn
life
scienc
neutrophil
cultur
upper
chamber
cell
supernat
collect
h
cocultur
bone
marrow
mice
collect
crush
layer
histopaqu
centrifug
cell
layer
contain
monocytesmacrophag
neutrophil
recov
wash
pb
fix
min
pfa
room
temperatur
cell
block
h
pb
contain
fc
room
temp
follow
stain
calreticulin
overnight
cell
wash
three
time
secondari
ad
incub
rt
h
wash
three
time
wash
buffer
contain
dapi
cell
imag
confoc
microscop
antimous
biolegend
antihuman
ebiosci
anticalreticulin
enzo
life
scienc
abcam
polyclon
anticrt
mbl
intern
antibodi
biolegend
bd
bioscienc
antibodi
biolegend
antimous
bd
bioscienc
antimous
ebiosci
antihuman
biolegend
antihuman
bd
bioscienc
bd
bioscienc
bd
bioscienc
bd
bioscienc
bd
bioscienc
bd
bioscienc
bd
bioscienc
use
fac
analys
antibodi
phycoerythrin
pe
pe
fitc
apc
brilliant
violet
conjug
fluorophoreconjug
secondari
antibodi
use
sytox
blue
use
exclud
dead
cell
cell
identifi
surfac
marker
neutrophil
macrophag
human
aml
sampl
use
popul
identifi
hsc
mpp
lsc
blast
cell
block
either
min
ice
stain
appropri
marker
min
ice
wash
acquir
sort
flow
cytomet
facsdiva
softwar
use
acquir
sort
cell
post
analysi
conduct
flowjo
softwar
human
aml
sampl
obtain
patient
stanford
medic
center
inform
consent
accord
institut
review
board
irb
approv
protocol
stanford
irb
crtbind
experi
cell
incub
recombin
calreticulin
human
fc
fusion
protein
biotinph
vector
laboratori
h
incub
ice
cell
wash
three
time
incub
antihuman
jackson
immunoresearch
invitrogen
min
ice
cell
wash
twice
costain
dapi
sigma
rel
fluoresc
analyz
flow
cytomet
bd
fortessa
wild
type
transgen
mice
inject
ml
thioglycol
induc
inflamm
four
eight
hour
inject
cell
extract
periton
caviti
bone
marrow
mous
fac
sort
directli
trizol
prior
total
rna
extract
chloroform
purif
qiagen
rneasi
minelut
cleanup
kit
total
rna
cdna
synthesi
amplif
carri
use
nugen
ovat
rnaseq
system
shear
use
covari
sizeselect
use
agincourt
ampur
xp
bead
librari
prepar
use
nebnext
ultra
rna
librari
prep
kit
illumina
use
illumina
truseq
adapt
barcod
depend
concentr
adaptorlig
cdna
determin
qubit
quantit
pcr
cycl
carri
amplifi
librari
agincourt
ampur
xp
bead
use
purifi
adapterlig
cdna
postamplif
sampl
multiplex
data
gener
illumina
hiseq
use
pairedend
bp
read
length
data
analyz
use
analysi
paramet
set
default
valu
pathway
analysi
conduct
use
total
rna
extract
describ
cdna
gener
use
superscript
iii
invitrogen
quantit
pcr
conduct
sybr
green
appli
biosystem
acquir
abi
follow
primer
sequenc
use
gapdh
fwd
accacagtccatgccatca
gapdh
rev
caccaccctgttgctgtagcc
crt
fwd
gcagaccctgccatctatttc
crt
rev
tcggacttatgtttggattcgac
vitro
phagocytosi
neutrophil
tumor
cell
macrophag
quantifi
facsbas
assay
differenti
mous
bonemarrowderiv
macrophag
human
peripher
bloodderiv
macrophag
detach
cultur
dish
trypl
scraper
divid
fac
tube
lowattach
plate
cell
per
well
per
tube
tumor
cell
prelabel
egfp
lenti
virus
neutrophil
stain
celltrac
calcein
dye
prior
experi
target
cell
tumor
cell
neutrophil
ad
mix
macrophag
imdm
medium
incub
h
indic
condit
antibodyenzym
treatment
blockad
interact
bd
bioscienc
antisirpa
biolegend
antibodi
use
antimous
antibodi
use
stain
macrophag
phagocyt
index
quantifi
fac
analys
calcul
number
macrophag
phagocytos
target
cell
divid
number
total
macrophag
experi
phagocyt
index
normal
maxim
index
altern
cell
load
lysotrack
red
probe
thermo
fisher
scientif
growth
medium
h
cell
wash
growth
medium
twice
imdm
medium
incub
macrophag
phagocytosi
excit
emiss
lysotrack
probe
nm
respect
lysotrack
probe
excit
phdepend
manner
highli
select
acid
organel
cancer
cell
load
lysotrack
probe
becom
posit
pe
channel
engulf
deliv
acid
organel
macrophag
digest
incub
target
cell
macrophag
one
engulf
target
cell
evalu
longterm
effect
phagocytosi
macrophag
target
cell
mix
cocultur
plate
h
indic
condit
antibodyenzym
treatment
cell
collect
trypl
antimous
antibodi
use
stain
macrophag
incub
cell
wash
fac
buffer
resuspend
fac
buffer
contain
sytox
blue
noncolor
standard
cell
cell
use
standard
cell
ad
prior
fac
analys
remain
target
cell
surviv
phagocytosi
macrophag
normal
standard
cell
number
standard
cell
fix
equal
sampl
evalu
effect
phagocytosi
differ
condit
measur
cell
viabil
neutrophil
macrophag
cancer
cell
wash
twice
pb
stain
annexinv
annexinvbind
buffer
min
room
temperatur
dark
annexinvbind
buffer
contain
cell
viabil
dye
dapi
sytox
blue
ad
cell
analyz
flow
cytometri
analys
cell
collect
fix
permeabil
follow
manufactur
recommend
bd
cytofixcytoperm
cell
block
bsa
pb
stain
calreticulin
mbl
overnight
cell
wash
three
time
pb
contain
tween
resuspend
cell
pellet
cell
centrifug
min
secondari
alexa
fluor
invitrogen
antibodi
use
cell
stain
h
room
temperatur
cell
wash
three
time
dapi
use
stain
nuclei
nm
invitrogen
confoc
imag
acquir
use
zeiss
imagej
use
overlay
imag
thioglycolateinduc
macrophag
isol
describ
macrophag
plate
cell
per
well
plate
label
clickit
aha
thermo
fisher
overnight
dmem
lmethionin
free
invitrogen
serum
macrophag
wash
cocultur
neutrophil
isol
describ
induct
periton
neutrophil
cocultur
macrophag
use
pore
transwel
h
neutrophil
wash
three
time
pb
cell
lyse
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
supplement
triton
proteas
inhibitor
cocktail
phosphatas
inhibitor
cocktail
brief
sonic
cell
lysat
incub
h
gammabind
plu
sepharos
preclear
overnight
anticrt
antibodi
gammabind
sepharos
ad
cell
lysat
incub
h
bead
wash
three
time
lysi
buffer
immunoprecipit
protein
elut
pb
supplement
sd
incub
biotin
alkyn
thermo
fisher
label
clickit
protein
reaction
buffer
kit
thermo
fisher
sampl
subject
sdspage
western
blot
hrpconjug
streptavidin
use
detect
biotinlabel
protein
load
control
lysat
neutrophil
macrophag
incub
methionin
analog
immunoprecipit
reduc
load
onto
sdspage
gel
stain
sypero
rubi
protein
gel
stain
visual
verifi
total
protein
content
sampl
supernat
collect
indic
time
first
centrifug
min
centrifug
min
store
immedi
calreticulin
measur
use
elisa
kit
lsbio
follow
manufactur
instruct
supernat
also
assess
solubl
factor
luminex
assay
stanford
human
immun
monitor
center
suppress
gene
express
perform
use
crispr
pair
primer
contain
sgrna
sequenc
target
human
gene
design
clone
allinon
lenticrispr
lentivir
vector
transfect
togeth
pack
plasmid
cell
viru
collect
h
transfect
ad
target
cell
target
cell
select
infect
puromycin
h
incub
viru
follow
sgrna
sequenc
use
control
lacz
carbohydr
antigen
variou
complex
dissolv
pb
glycoprotein
conjug
salin
polysaccharid
spot
onto
superepoxi
protein
slide
arrayit
corpor
sunnyval
ca
immedi
use
print
microarray
slide
wash
pb
rt
min
block
bsapb
rt
min
incub
recombin
crtiggfc
rt
h
follow
wash
incub
goat
antimous
iggfc
secondari
antibodi
rt
min
stain
slide
rins
five
time
spindri
room
temperatur
scan
fluoresc
signal
microarray
scanner
perkinelm
life
scienc
use
scan
stain
microarray
fluoresc
intens
valu
array
spot
background
calcul
use
scanarray
express
softwar
perkinelm
life
scienc
freestyl
cell
thermo
fisher
scientif
use
express
crt
recombin
protein
accord
manufactur
instruct
briefli
vector
express
hcrtiggfc
transfect
cell
fectin
ml
per
plasmid
dna
cell
cultur
freestyl
express
medium
thermo
fisher
scientif
incub
orbit
shaker
platform
rotat
rpm
total
day
transfect
supernat
collect
flow
hitrap
protein
hp
column
purifi
protein
elut
column
glycin
ph
neutral
trisbuff
ph
elut
protein
buffer
chang
pb
ph
repeat
centrifug
ultracentrifug
filter
concentr
millipor
cell
neutrophil
tumor
cell
wash
pb
incub
buffer
dmem
medium
supplement
mm
bsa
total
cell
treat
u
cholera
incub
buffer
h
incub
cell
wash
twice
imdm
medium
subject
phagocytosi
assay
fac
analys
cell
treat
neuraminidas
heatinactiv
neuraminidas
wash
twice
dmem
medium
suspend
dmem
medium
matrix
matrigel
cell
inject
subcutan
back
nsg
mice
week
old
tumor
cell
surviv
growth
vivo
monitor
bioluminesc
imag
describ
briefli
dluciferin
firefli
potassium
salt
dissolv
pb
final
concentr
mg
inject
intraperiton
mice
dose
g
luciferin
bodi
weight
bioluminesc
imag
perform
daili
everi
day
mice
imag
tumor
signal
analyz
live
imag
softwar
data
collect
statist
analyz
graph
either
microsoft
excel
prism
graphpad
softwar
rnaseq
data
report
paper
deposit
gene
express
omnibu
databas
access
code
author
declar
data
support
find
studi
avail
within
articl
supplementari
inform
file
correspond
author
upon
reason
request
